High doses of vascular endothelial growth factor 165 safely, but transiently, improve myocardial perfusion in no-option ischemic disease

Human Gene Therapy Methods

Volumn 24, Issue 5, 2013, Pages 298-306

  Giusti, Imarilde I ^a   Rodrigues, Clarissa G ^a,b   Salles, Felipe B ^a   Sant'Anna, Roberto T ^a   Eibel, Bruna ^a   Han, Sang W ^c   Ludwig, Eduardo ^a   Grossman, Gabriel ^a   Prates, Paulo Roberto L ^a   Sant'Anna, João Ricardo M ^a   Filho, Guaracy F Teixeira ^a   Markoski, Melissa M ^a   Nesralla, Ivo A ^a   Nardi, Nance B ^a   Kalil, Renato A K ^a,d  

^a INSTITUTO DE CARDIOLOGIA DO RIO GRANDE DO SUL   (Brazil)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^d UNIVERSIDADE FEDERAL DE CIÊNCIAS DA SAÚDE DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

VASCULOTROPIN 165;

ADULT; ANGINA PECTORIS; ARTICLE; CARDIOVASCULAR GENE THERAPY; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG MEGADOSE; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HUMAN; ISCHEMIC CARDIOMYOPATHY; MALE; OXYGEN CONSUMPTION; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; REFRACTORY ANGINA; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT DURATION;

AGED; ANGINA PECTORIS; EXERCISE TEST; FEMALE; GENETIC THERAPY; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; PROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84885131010     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2012.221     Document Type: Article

References (22)

1. Bokeriia, L.A., Golukhova, E.Z., Eremeeva, M.V., et al. (2004). New approaches to the treatment of ischemic heart disease: therapeutic angiogenesis in combination with surgical revascularization of the myocardium. Ter. Arkh. 76, 25-30. (Pubitemid 38843937)
2. Bokeriya, L.A., Golukhova, E.Z., Eremeeva, M.V., et al. (2005). Use of human VEGF(165) gene for therapeutic angiogenesis in coronary patients: first results. Bull. Exp. Biol. Med. 140, 106-112. (Pubitemid 41548644)
3. Carvalho, V.O., Guimaraes, G.V., Carrara, D., et al. (2009). Validation of the Portuguese version of the Minnesota Living with Heart Failure Questionnaire. Arq. Bras. Cardiol. 93, 39-44.
4. Fortuin, F.D., Vale, P., Losordo, D.W., et al. (2003). One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients. Am. J. Cardiol. 92, 436-439. (Pubitemid 36959880)
5. Furlani, A.P., Kalil, R.A., Castro, I., et al. (2009). Effects of therapeutic angiogenesis with plasmid VEGF165 on ventricular function in a canine model of chronic myocardial infarction. Rev. Bras. Cir. Cardiovasc. 24, 143-149.
6. Heeschen, C., Lehmann, R., Honoldn, J., et al. (2004). Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109, 1615-1622. (Pubitemid 38451717)
7. Hughes, G.C., Biswas, S.S., Yin, B., et al. (2004). Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF. Ann. Thorac. Surg. 77, 812-818. (Pubitemid 38292073)
8. Kalil, R.A., Salles, F.B., Giusti, I.I., et al. (2010). VEGF gene therapy for angiogenesis in refractory angina: phase I/II clinical trial. Rev. Bras. Cir. Cardiovasc. 25, 311-321.
9. Kastrup, J. (2010). Gene therapy and angiogenesis in patients with coronary artery disease. Expert Rev. Cardiovasc. Ther. 8, 1127-1138.
10. Kastrup, J., Jorgensen, E., Ruck, A., et al. (2005). Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris: a randomized double-blind placebo-controlled study: the Euroinject One trial. J. Am. Coll. Cardiol. 45, 982-988. (Pubitemid 40432426)
11. Ko1sut, P., Ma1ecki, M., Firek, B., et al. (2004). Gene therapy with phVEGF165 plasmid-preliminary report. Kardiol. Pol. 60 Suppl. 1, 82-89.
12. Losordo, D.W., Vale, P.R., Symes, J.F., et al. (1998). Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98, 2800-2804. (Pubitemid 29003959)
13. Losordo, D.W., Vale, P.R., Hendel, R.C., et al. (2002). Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 105, 2012-2018. (Pubitemid 34465261)
14. McGillion, M., Watt-Watson, J., LeFort, S., et al. (2007). Positive shifts in the perceived meaning of cardiac pain following a psychoeducation program for chronic stable angina. Can. J. Nurs. Res. 39, 48-65.
15. Ruel, M., Beanlands, R.S., Lortie, M., et al. (2008). Concomitant treatment with oral L-arginine improves the efficacy of surgical angiogenesis in patients with severe diffuse coronary artery disease: the Endothelial Modulation in Angiogenic Therapy randomized controlled trial. J. Thorac. Cardiovasc. Surg. 135, 762-770.
16. Sarkar, N., Ruck, A., Kallner, G., et al. (2001). Effects of intramyocardial injection of phVEGF-A165 as sole therapy in patients with refractory coronary artery disease-12-month follow-up: angiogenic gene therapy. J. Intern. Med. 250, 373-381. (Pubitemid 32990045)
17. Stewart, D.J., Hilton, J.D., Arnold, J.M., et al. (2006). Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of Ad-VEGF(121) (AdVEGF121) versus maximum medical treatment. Gene Ther. 13, 1503-1511. (Pubitemid 44574158)
18. Stewart, D.J., Kutryk, M.J., Fitchett, D., et al. (2009). VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. Mol. Ther. 17, 1109-1115.
19. Symes, J.F., Losordo, D.W., Vale, P.R., et al. (1999). Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease. Ann. Thorac. Surg. 68, 830-836.
20. Vale, P.R., Losordo, D.W., Milliken, C.E., et al. (2000). Left ventricular electromechanical mapping to assess efficacy of phVEGF(165) gene transfer for therapeutic angiogenesis in chronic myocardial ischemia. Circulation 102, 965-974. (Pubitemid 30656004)
21. Yang, E.H., Barsness, G.W., Gersh, B.J., et al. (2004). Current and future treatment strategies for refractory angina. Mayo Clin. Proc. 79, 1284-1292. (Pubitemid 39299074)
22. Zachary, I., and Morgan, R.D. (2011). Therapeutic angiogenesis for cardiovascular disease: biological context, challenges, prospects. Heart 97, 181-189.